Lentiviral vector-mediated RNAi and its use for cancer research

Hidetoshi Sumimoto, Yutaka Kawakami

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

RNAi is a useful tool for functional analysis of genes and developing a potential therapeutic strategy for various diseases including cancers. RNAican be applied in various forms. HIV vectors are useful for the stable transduction of genes to both replicating and quiescent cells with a broad host tropism, and have been developed for basic and clinical research of gene therapy. HIV vectors can deliver shRNAs for post-transcriptional silencing of specific genes with high efficiency, and have been used to evaluate various genes far their potential involvement in cancer development and malignant features, and may be useful for future cancer gene therapy. Here we describe the development of shRNA-expressing HIV vectors and their use in cancer research, as well as perspectives for their future use in cancer gene therapy.

Original languageEnglish
Pages (from-to)655-664
Number of pages10
JournalFuture Oncology
Volume3
Issue number6
DOIs
Publication statusPublished - 2007 Dec

Fingerprint

RNA Interference
Genetic Therapy
Neoplasm Genes
HIV
Viral Tropism
Research
Genes
Neoplasms
Small Interfering RNA
Therapeutics

Keywords

  • Cancer
  • Gene therapy
  • HIV
  • Lentiviral vector
  • RNAi
  • shRNA

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Lentiviral vector-mediated RNAi and its use for cancer research. / Sumimoto, Hidetoshi; Kawakami, Yutaka.

In: Future Oncology, Vol. 3, No. 6, 12.2007, p. 655-664.

Research output: Contribution to journalArticle

Sumimoto, Hidetoshi ; Kawakami, Yutaka. / Lentiviral vector-mediated RNAi and its use for cancer research. In: Future Oncology. 2007 ; Vol. 3, No. 6. pp. 655-664.
@article{3ac2b896985c4b6aa3ffe48e207d9e76,
title = "Lentiviral vector-mediated RNAi and its use for cancer research",
abstract = "RNAi is a useful tool for functional analysis of genes and developing a potential therapeutic strategy for various diseases including cancers. RNAican be applied in various forms. HIV vectors are useful for the stable transduction of genes to both replicating and quiescent cells with a broad host tropism, and have been developed for basic and clinical research of gene therapy. HIV vectors can deliver shRNAs for post-transcriptional silencing of specific genes with high efficiency, and have been used to evaluate various genes far their potential involvement in cancer development and malignant features, and may be useful for future cancer gene therapy. Here we describe the development of shRNA-expressing HIV vectors and their use in cancer research, as well as perspectives for their future use in cancer gene therapy.",
keywords = "Cancer, Gene therapy, HIV, Lentiviral vector, RNAi, shRNA",
author = "Hidetoshi Sumimoto and Yutaka Kawakami",
year = "2007",
month = "12",
doi = "10.2217/14796694.3.6.655",
language = "English",
volume = "3",
pages = "655--664",
journal = "Future Oncology",
issn = "1479-6694",
publisher = "Future Medicine Ltd.",
number = "6",

}

TY - JOUR

T1 - Lentiviral vector-mediated RNAi and its use for cancer research

AU - Sumimoto, Hidetoshi

AU - Kawakami, Yutaka

PY - 2007/12

Y1 - 2007/12

N2 - RNAi is a useful tool for functional analysis of genes and developing a potential therapeutic strategy for various diseases including cancers. RNAican be applied in various forms. HIV vectors are useful for the stable transduction of genes to both replicating and quiescent cells with a broad host tropism, and have been developed for basic and clinical research of gene therapy. HIV vectors can deliver shRNAs for post-transcriptional silencing of specific genes with high efficiency, and have been used to evaluate various genes far their potential involvement in cancer development and malignant features, and may be useful for future cancer gene therapy. Here we describe the development of shRNA-expressing HIV vectors and their use in cancer research, as well as perspectives for their future use in cancer gene therapy.

AB - RNAi is a useful tool for functional analysis of genes and developing a potential therapeutic strategy for various diseases including cancers. RNAican be applied in various forms. HIV vectors are useful for the stable transduction of genes to both replicating and quiescent cells with a broad host tropism, and have been developed for basic and clinical research of gene therapy. HIV vectors can deliver shRNAs for post-transcriptional silencing of specific genes with high efficiency, and have been used to evaluate various genes far their potential involvement in cancer development and malignant features, and may be useful for future cancer gene therapy. Here we describe the development of shRNA-expressing HIV vectors and their use in cancer research, as well as perspectives for their future use in cancer gene therapy.

KW - Cancer

KW - Gene therapy

KW - HIV

KW - Lentiviral vector

KW - RNAi

KW - shRNA

UR - http://www.scopus.com/inward/record.url?scp=38049103157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38049103157&partnerID=8YFLogxK

U2 - 10.2217/14796694.3.6.655

DO - 10.2217/14796694.3.6.655

M3 - Article

C2 - 18041918

AN - SCOPUS:38049103157

VL - 3

SP - 655

EP - 664

JO - Future Oncology

JF - Future Oncology

SN - 1479-6694

IS - 6

ER -